Tianci International (CIIT) receives Nasdaq $1.00 bid price notice
Tianci International (CIIT) reported a Nasdaq notice that its shares failed to meet the $1.00 minimum bid price for 30 consecutive business days under Listing Rule 5550(a)(2).
Rhea-AI Filing Summary
Tianci International (CIIT) reported a Nasdaq notice that its shares failed to meet the $1.00 minimum bid price for 30 consecutive business days under Listing Rule 5550(a)(2). The notice has no immediate effect on the listing.
The company has 180 calendar days, until April 27, 2026, to regain compliance. Compliance is achieved if the closing bid price is at least $1.00 for a minimum of 10 consecutive business days. If still noncompliant by the deadline, Tianci may qualify for an additional grace period if other initial listing standards are met, or it may receive a delisting notice with the right to appeal. Tianci plans to monitor its closing bid and consider available options.
Positive
- None.
Negative
- None.
Insights
Nasdaq bid-price deficiency with a defined 180-day cure window.
Tianci International disclosed a deficiency under Nasdaq’s Rule 5550(a)(2) after 30 straight business days below a $1.00 bid. The notice does not immediately affect trading on the Nasdaq Capital Market.
The company has until April 27, 2026 to cure by maintaining a closing bid of at least $1.00 for 10 consecutive business days. If unmet, an additional grace period may be available if other initial listing standards are satisfied.
Failure to regain compliance could lead to a delisting notice, which the company could appeal to a Nasdaq Hearings Panel. Actual outcomes depend on share price performance and eligibility determinations.
8-K Event Classification
FAQ
What did Tianci International (CIIT) disclose?
Does the Nasdaq notice immediately affect CIIT’s listing?
What is the deadline for CIIT to regain compliance?
How can CIIT regain compliance with Nasdaq’s bid-price rule?
What happens if CIIT does not regain compliance by the deadline?
What actions did CIIT say it will take?
AI-generated analysis. How Rhea-AI works. Not financial advice.